Gf Fund Management Co. Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
CIK
0002057060
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
SEC
Search and click to pin securities to the top
Page 33 of 34
Alector, Inc.
ALEC|014442107
Shares:
2429(+13.2%)
Value:
$3.0M(-26.3%)
ENANTA PHARMACEUTICALS INC
ENTA|29251M106
Shares:
525(+18.0%)
Value:
$2.9M(+13.2%)
Lexeo Therapeutics, Inc.
LXEO|52886X107
Shares:
820(+18.1%)
Value:
$2.8M(-37.7%)
C4 Therapeutics, Inc.
CCCC|12529R107
Shares:
1751(+18.1%)
Value:
$2.8M(-47.5%)
Editas Medicine, Inc.
EDIT|28106W103
Shares:
2113(+15.5%)
Value:
$2.5M(+5.5%)
FATE THERAPEUTICS INC
FATE|31189P102
Shares:
2737(+14.5%)
Value:
$2.2M(-45.2%)
Kyverna Therapeutics, Inc.
KYTX|501976104
Shares:
1070(+18.1%)
Value:
$2.1M(-39.0%)
PLIANT THERAPEUTICS, INC.
PLRX|729139105
Shares:
1509(+18.1%)
Value:
$2.0M(-87.9%)
MACROGENICS INC
MGNX|556099109
Shares:
1557(+18.1%)
Value:
$2.0M(-53.9%)
28658R106
28658R106
Shares:
1616(+14.4%)
Value:
$2.0M(-22.4%)
Biomea Fusion, Inc.
BMEA|09077A106
Shares:
899(+14.7%)
Value:
$1.9M(-37.0%)
Hewlett Packard Enterprise Co
HPE|42824C109
Shares:
123
Value:
$1.9M
Artiva Biotherapeutics, Inc.
ARTV|04317A107
Shares:
603(+18.2%)
Value:
$1.8M(-64.8%)
TScan Therapeutics, Inc.
TCRX|89854M101
Shares:
1218(+18.1%)
Value:
$1.7M(-46.4%)
Acrivon Therapeutics, Inc.
ACRV|004890109
Shares:
772(+18.0%)
Value:
$1.6M(-60.2%)
Inozyme Pharma, Inc.
INZY|45790W108
Shares:
1544(+14.4%)
Value:
$1.4M(-62.4%)
Pyxis Oncology, Inc.
PYXS|747324101
Shares:
1429(+14.4%)
Value:
$1.4M(-28.1%)
OnKure Therapeutics, Inc.
OKUR|68277Q105
Shares:
313(+17.7%)
Value:
$1.3M(-41.2%)
SUTRO BIOPHARMA, INC.
STRO|869367102
Shares:
1982(+14.5%)
Value:
$1.3M(-59.5%)
PepGen Inc.
PEPG|713317105
Shares:
808(+18.1%)
Value:
$1.1M(-56.2%)